The DOI matches its Crossref record.
DNase inhibits early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models
Abstract
Anti-infection strategies against pleural empyema include the use of antibiotics and drainage treatments, but bacterial eradication rates remain low. A major challenge is the formation of biofilms in the pleural cavity. DNase has antibiofilm efficacy in vitro, and intrapleural therapy with DNase is recommended to treat pleural empyema, but the relevant mechanisms remain limited. Our aim was to investigate whether DNase I inhibit the early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models. We used various assays, such as crystal violet staining, confocal laser scanning microscopy (CLSM) analysis, peptide nucleic acid-fluorescence in situ hybridization (PNA-FISH), and scanning electron microscopy (SEM) analysis. Our results suggested that DNase I significantly inhibited early biofilm formation in a dose-dependent manner, without affecting the growth of P. aeruginosa or S. aureus in vitro. CLSM analysis confirmed that DNase I decreased the biomass and thickness of both bacterial biofilms. The PNA-FISH and SEM analyses also revealed that DNase I inhibited early (24h) biofilm formation in two empyema models. Thus, the results indicated that DNase inhibited early (24h) biofilm formation in P. aeruginosa- or S. aureus-induced rabbit empyema models and showed its therapeutic potential against empyema biofilms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“eDNA acts as a load-bearing scaffold that interacts with Psl to create a skeletal lattice within the matrix. Treatment with DNase weakens this scaffold and improves antimicrobial penetration, particularly in early-stage biofilms [41,42].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 63
- Addala, 2021, Parapneumonic effusion and empyema, Clin. Chest Med., 42, 637, 10.1016/j.ccm.2021.08.001 · doi:10.1016/j.ccm.2021.08.001
- Alhede, 2020, The origin of extracellular DNA in bacterial biofilm infections in vivo, Pathog. Dis., 78, 10.1093/femspd/ftaa018 · DOI
- Banu, 2017, Antivirulent properties of underexplored cinnamomum tamala essential oil and its synergistic effects with DNase against pseudomonas aeruginosa biofilms – an In vitro study, Front. Microbiol., 8, 10.3389/fmicb.2017.01144 · DOI
- Bedawi, 2021, Advances in pleural infection and malignancy, Eur. Respir. Rev., 30, 10.1183/16000617.0002-2020 · DOI
- Bedawi, 2019, Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics, Expert Rev. Respir. Med., 13, 337, 10.1080/17476348.2019.1578212 · doi:10.1080/17476348.2019.1578212
- Buzzo, 2021, Z-form extracellular DNA is a structural component of the bacterial biofilm matrix, Cell, 184, 5740, 10.1016/j.cell.2021.10.010 · DOI · Paper page
- Chaddha, 2021, Use of fibrinolytics and deoxyribonuclease in adult patients with pleural empyema: a consensus statement, Lancet Respir. Med., 9, 1050, 10.1016/S2213-2600(20)30533-6 · DOI
- Chávez de Paz, 2008, Oral bacteria in biofilms exhibit slow reactivation from nutrient deprivation, Microbiol. (Reading England), 154, 1927, 10.1099/mic.0.2008/016576-0 · DOI
- Chen, 2021, Identification of microbiome etiology associated with drug resistance in pleural empyema, Front. Cell Infect. Microbiol., 11, 10.3389/fcimb.2021.637018 · DOI
- Chen, 2016, Baicalein inhibits staphylococcus aureus biofilm formation and the quorum sensing system In vitro, PloS One, 11, 10.1371/journal.pone.0153468 · DOI · Paper page
- Coelho, 2021, Pyranoanthocyanins interfering with the quorum sensing of pseudomonas aeruginosa and staphylococcus aureus, Int. J. Mol. Sci., 22, 8559, 10.3390/ijms22168559 · DOI
- Davide, 2021, Extracellular DNA (eDNA). a major ubiquitous element of the bacterial biofilm architecture, Int. J. Mol. Sci., 22, 9100, 10.3390/ijms22169100 · DOI · Paper page
- Elsayed, 2018, Thoracoscopic management of early stages of empyema: is this the golden standard, J. Vis. Surg., 4, 114, 10.21037/jovs.2018.05.18 · doi:10.21037/jovs.2018.05.18
- Farisa Banu, 2017, Antivirulent properties of underexplored cinnamomum tamala essential oil and its synergistic effects with DNase against pseudomonas aeruginosa biofilms - an In vitro study, Front. Microbiol., 8, 10.3389/fmicb.2017.01144 · DOI
- Hall, 2017, Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria, FEMS Microbiol. Rev., 41, 276, 10.1093/femsre/fux010 · DOI · Paper page
- Hartmann, 2021, Quantitative image analysis of microbial communities with BiofilmQ, Nat. Microbiol., 6, 151, 10.1038/s41564-020-00817-4 · DOI · Paper page
- Hassan, 2019, The microbiology of pleural infection in adults: a systematic review, Eur. Respir. J., 54, 1900542, 10.1183/13993003.00542-2019 · DOI
- Heydorn, 2000, Quantification of biofilm structures by the novel computer program COMSTAT, Microbiology-Sgm, 146, 2395, 10.1099/00221287-146-10-2395 · DOI · Paper page
- Idell, 2017, Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: The case for the fibrinolytic potential, Clin. Pulm Med., 24, 163, 10.1097/CPM.0000000000000216 · doi:10.1097/cpm.0000000000000216
- Jelle, 2022, The dynamic transcriptome during maturation of biofilms formed by methicillin-resistant staphylococcus aureus&13, Front. Microbiol., 13, 10.3389/fmicb.2022.882346 · doi:10.3389/fmicb.2022.882346
- KaiLing, 2022, Anti-larval and anti-algal natural products from marine microorganisms as sources of anti-biofilm agents, Mar. Drugs, 20, 90, 10.3390/md20020090 · doi:10.3390/md20020090
- Kaplan, 2012, Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci, J. Antibiotics, 65, 73, 10.1038/ja.2011.113 · DOI · Paper page
- Karygianni, 2020, Combined DNase and proteinase treatment interferes with composition and structural integrity of multispecies oral biofilms, J. Clin. Med., 9, 983, 10.3390/jcm9040983 · DOI
- Karygianni, 2021, Single DNase or proteinase treatment induces change in composition and structural integrity of multispecies oral biofilms, Antibiotics (Basel), 10, 400, 10.3390/antibiotics10040400 · DOI
- Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies, Nat. Rev. Microbiol., 15, 740, 10.1038/nrmicro.2017.99 · DOI · Paper page
- Krychowiak, 2014, Combination of silver nanoparticles and drosera binata extract as a possible alternative for antibiotic treatment of burn wound infections caused by resistant staphylococcus aureus, PloS One, 9, 10.1371/journal.pone.0115727 · DOI
- Kumar, 2019, Antibiofilm potential of silver sulfadiazine-loaded nanoparticle formulations: A study on the effect of DNase-I on microbial biofilm and wound healing activity, Mol. pharmaceutics, 16, 3916, 10.1021/acs.molpharmaceut.9b00527 · DOI
- Lacotte, 2022, Inhibition of In vitro clostridioides difficile biofilm formation by the probiotic yeast saccharomyces boulardii CNCM I-745 through modification of the extracellular matrix composition, Microorganisms, 10, 1082, 10.3390/microorganisms10061082 · DOI
- Lee, 2011, 3-indolylacetonitrile decreases escherichia coli O157:H7 biofilm formation and pseudomonas aeruginosa virulence, Environ. Microbiol., 13, 62, 10.1111/j.1462-2920.2010.02308.x · DOI · Paper page
- Lehtomaki, 2020, Pleural infection-an indicator of morbidity and increased burden on health care, Interact. Cardiovasc. Thorac. Surg., 31, 513, 10.1093/icvts/ivaa147 · doi:10.1093/icvts/ivaa147
- Lehtomaki, 2020, Trends in the incidence, etiology, treatment, and outcomes of pleural infections in adults over a decade in a Finnish university hospital, Scand. J. Surg., 109, 127, 10.1177/1457496919832146 · doi:10.1177/1457496919832146
- Liu, 2020, Encapsulated DNase improving the killing efficiency of antibiotics in staphylococcal biofilms, J. Mater Chem. B, 8, 4395, 10.1039/d0tb00441c · DOI
- Lukas, 2006, Analysis of a marine phototrophic biofilm by confocal laser scanning microscopy using the new image quantification software PHLIP, BMC Ecol., 6, 10.1186/1472-6785-6-1 · DOI · Paper page
- Luo, 2018, A sensitive thresholding method for confocal laser scanning microscope image stacks of microbial biofilms, Sci. Rep., 8, 13013, 10.1038/s41598-018-31012-5 · DOI
- Luo, 2016, Baicalein attenuates the quorum sensing-controlled virulence factors of pseudomonas aeruginosa and relieves the inflammatory response in p. aeruginosa-infected macrophages by downregulating the MAPK and NFkappaB signal-transduction pathways, Drug Des. Devel Ther., 10, 183, 10.2147/DDDT.S97221 · DOI
- Meraj, 2020, Anacardic acid encapsulated solid lipid nanoparticles for staphylococcus aureus biofilm therapy: chitosan and DNase coating improves antimicrobial activity, Drug deliv Trans. Res., 11, 305, 10.1007/s13346-020-00795-4 · DOI
- Mountcastle, 2021, Biofilm viability checker: An open-source tool for automated biofilm viability analysis from confocal microscopy images, NPJ Biofilms Microbiomes, 7, 44, 10.1038/s41522-021-00214-7 · DOI · Paper page
- Nourbakhsh, 2022, Bacterial biofilms and their resistance mechanisms: a brief look at treatment with natural agents, Folia Microbiol. (Praha), 67, 535, 10.1007/s12223-022-00955-8 · DOI
- Panlilio, 2021, The role of extracellular DNA in the formation, architecture, stability, and treatment of bacterial biofilms, Biotechnol. Bioeng, 118, 2129, 10.1002/bit.27760 · DOI · Paper page
- Pezzoni, 2020, Evaluation of viable cells in pseudomonas aeruginosa biofilmsby colony count and Live/Dead staining, Bio Protoc., 10, 10.21769/BioProtoc.3762 · DOI
- Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res., 29, 10.1093/nar/29.9.e45 · DOI · Paper page
- Rahman, 2011, Intrapleural use of tissue plasminogen activator and DNase in pleural infection, N Engl. J. Med., 365, 518, 10.1056/NEJMoa1012740 · DOI · Paper page
- Rajendran, 2013, Extracellular DNA release acts as an antifungal resistance mechanism in mature aspergillus fumigatus biofilms, Eukaryot Cell, 12, 420, 10.1128/EC.00287-12 · DOI · Paper page
- Ramaraj, 2020, Combined effect of melittin and DNase on enterococcus faecalis biofilms and its susceptibility to sodium hypochlorite, Materials (Basel), 13, 3740, 10.3390/ma13173740 · DOI
- Rather, 2021, Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies, Braz. J. Microbiol., 52, 1701, 10.1007/s42770-021-00624-x · DOI · Paper page
- Rybtke, 2015, Pseudomonas aeruginosa biofilm infections: Community structure, antimicrobial tolerance and immune response, J. Mol. Biol., 427, 3628, 10.1016/j.jmb.2015.08.016 · DOI · Paper page
- Saharut, 2020, DNase-mediated eDNA removal enhances d-LL-31 activity against biofilms of bacteria isolated from chronic rhinosinusitis patients, Biofouling, 36, 1117, 10.1080/08927014.2020.1857741 · DOI
- Schlafer, 2018, Effect of DNase treatment on adhesion and early biofilm formation of enterococcus faecalis, Eur. Endod. J., 3, 82, 10.14744/eej.2018.55264 · DOI
- Shang, 2022, Clemastine inhibits the biofilm and hemolytic of staphylococcus aureus through the GdpP protein, Microbiol. Spectr., 10, e0054121, 10.1128/spectrum.00541-21 · DOI
- Sharma, 2019, Antibiotics versus biofilm: an emerging battleground in microbial communities, Antimicrobial Resist Infect Control, 8, 76, 10.1186/s13756-019-0533-3 · DOI · Paper page
- Sharma, 2018, Antibiofilm effect of DNase against single and mixed species biofilm, Foods, 7, 42, 10.3390/foods7030042 · DOI
- Sladjana, 2009, Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH), Microbiol. (Reading England), 155, 8), 10.1099/mic.0.028712-0 · DOI · Paper page
- Srikanth, 2021, Biosurfactant synergized with marine bacterial DNase disrupts polymicrobial biofilms, Folia Microbiol. (Praha), 66, 831, 10.1007/s12223-021-00876-y · DOI
- Sundaralingam, 2021, Management of pleural infection, Pulm Ther., 7, 59, 10.1007/s41030-020-00140-7 · doi:10.1007/s41030-020-00140-7
- Tetz, 2009, Effect of DNase and antibiotics on biofilm characteristics, Antimicrob. Agents Chemother., 53, 1204, 10.1128/AAC.00471-08 · DOI · Paper page
- Tsiry, 2015, The formation of biofilms by pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms, BioMed. Res. Int., 2015, 10.1155/2015/759348 · DOI · Paper page
- Wang, 2020, The characteristic of virulence, biofilm and antibiotic resistance of klebsiella pneumoniae, Int. J. Environ. Res. Public Health, 17, 6278, 10.3390/ijerph17176278 · DOI · Paper page
- Wei, 2019, Insulin treatment enhances pseudomonas aeruginosa biofilm formation by increasing intracellular cyclic di-GMP levels, leading to chronic wound infection and delayed wound healing, Am. J. Transl. Res., 11, 3261
- Xu, 2015, [Effect of DNase I on biofilm formation of staphylococcus aureus], Nan Fang Yi Ke Da Xue Xue Bao, 35, 1356
- Yin, 2022, Caffeic acid phenethyl ester (CAPE) inhibits cross-kingdom biofilm formation of streptococcus mutans and candida albicans, Microbiol. Spectrum, 10.1128/spectrum.01578-22 · DOI
- Yu, 2022, Andrographolide inhibits biofilm and virulence in listeria monocytogenes as a quorum-sensing inhibitor, Molecules, 27, 3234, 10.3390/molecules27103234 · doi:10.3390/molecules27103234
- Zhang, 2020, The effect of cyclic-di-GMP on biofilm formation by pseudomonas aeruginosa in a novel empyema model, Ann. Transl. Med., 8, 1146, 10.21037/atm-20-6022 · DOI
- Zhu, 2006, Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model, Chest, 129, 1577, 10.1378/chest.129.6.1577 · doi:10.1378/chest.129.6.1577
Cited by
Elbehiry, A., Marzouk, E., Edrees, H. M., Ibrahem, M., Alzahrani, S., Anagreyyah, S., Abualola, H., Alghamdi, A., Alzahrani, A., Jaber, M., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14010109 · Cited by 34
Metadata
- Authors
- Deng, W., Lei, Y., Tang, X., Li, D., Liang, J., Luo, J., Liu, L., Zhang, W., Ye, L., Kong, J., Wang, K., & Chen, Z.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-10-12
- Volume
- 12
- ISSN
- 2235-2988
- Cited by
- 50
- References
- 0
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DNase inhibits early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models. https://app.cochat.ai/papers/10.3389/fcimb.2022.917038
- The paper
- Deng, W., Lei, Y., Tang, X., Li, D., Liang, J., Luo, J., Liu, L., Zhang, W., Ye, L., Kong, J., Wang, K., & Chen, Z. (2022). DNase inhibits early biofilm formation in Pseudomonas aeruginosa- or Staphylococcus aureus-induced empyema models. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2022.917038
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.